This correlation was not evident in tumors treated with the vehicle alone, confirming that HES1 might be a predictive biomarker of efficacy and plays a relevant role in the mechanism of 2OHOA to induce tumor shrinkage in those that respond to this treatment. This evidence concerns the gene HES1 and neoplasm.